文献速递临床试验与 GCP真实世界研究与卫生经济医学人工智能与信息学

推广和扩展电子处方精简软件以改善养老院老年人健康结局:阶梯楔形整群随机试验的研究方案

Spread and scale of an electronic deprescribing software to improve health outcomes of older adults living in nursing homes: study protocol for a stepped wedge cluster randomized trial.
PubMed 文献 · Trials · 2021-11-02

该研究采用混合方法2型实效-实施混合设计,计划在加拿大新不伦瑞克省5家长期护理机构招募约1000名居民,开展阶梯楔形整群随机试验,评估MedReviewRx软件辅助药物审查对减少潜在不适当用药的影响,主要结局为处方审查后90天内至少一种潜在不适当用药被精简的患者比例。

要点

  • 研究计划纳入约1000名长期护理居民,来自5家机构,干预期18个月。
  • 主要结局为处方审查后90天内至少一种潜在不适当用药被精简的患者比例。
  • 采用阶梯楔形整群随机设计,每3个月一个新集群进入干预,各集群自身前后对照。

核心结论

  • 该研究方案旨在评估MedReviewRx软件辅助药物审查对长期护理机构老年人药物过度负荷的影响,并收集潜在不适当用药使用、成本节约及药物审查和处方精简的促进因素与挑战等信息。

研究设计与样本

  • 采用混合方法2型实效-实施混合设计,实效部分为阶梯楔形整群随机试验。
  • 计划从加拿大新不伦瑞克省5家长期护理机构招募约1000名居民,研究开始时收集3个月基线处方精简率数据,此后每3个月一个新集群进入干预模式,预计研究时长18个月。

主要发现

  • 原文未报告研究结果。

关键数值与推荐

  • 主要结局为处方审查后90天内至少一种潜在不适当用药被精简(减量/停药或换用更安全的替代药物)的患者比例。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Medication overload or problematic polypharmacy is a major problem causing widespread harm, particularly to older adults. Taking multiple medications increases the risk of potentially inappropriate medications (PIMs), and residents in long-term care (LTC) are frequently prescribed 10 or more medications at once. One strategy to address this problem is for the physician and/or pharmacist to perform regular medication reviews; however, this process can be complicated and time-consuming. With a prescription review, medications may be decreased, changed, or stopped altogether. MedReviewRx is a software that runs an analysis using deprescribing rules to produce a report to guide medication reviews addressing medication overload for residents in LTC. METHODS: This study will employ a mixed methods effectiveness-implementation hybrid type 2 study design. To measure effectiveness, a stepped wedge cluster randomized trial design is planned, which allows us to approximate a randomized clinical trial. Approximately 1000 residents living in LTC will be recruited from five facilities in New Brunswick. The study will begin with 3 months of baseline data on rates of deprescribing. Thereafter, every 3 months a new cluster will enter the intervention mode. The intervention consists of medication reviews augmented with the MedReviewRx software, which will be used by staff and clinicians in the facilities. The estimated study duration is 18 months and the main outcome will be the proportion of patients with one or more PIMs deprescribed (reduced/stopped or changed to a safer alternative) in the 90 days following a prescription review. The goal is to study the impact of MedReviewRx on medication overload among older adults living in LTC. In typical fashion of a stepped wedge cluster randomized trial, each cluster acts as an internal control (before and after) as well as a control for the other clusters (external control). Qualitative data collected will include resident/caregiver attitudes towards deprescribing and semi-structured interviews with staff working in the long-term care homes. DISCUSSION: This study design addresses issues with seasonality and allows all clusters to participate in the intervention, which is an advantage when the intervention is related to quality improvement. This study will provide valuable information on PIM use, cost savings, and facilitators and challenges associated with medication reviews and deprescribing. This study represents an important step towards understanding and promoting tools to guide safe and rational reduction of PIM use among older adults. TRIAL REGISTRATION: NCT04762303 , Registered February 21, 2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Nadeau ME, Henry JL, Lee TC, et al. Spread and scale of an electronic deprescribing software to improve health outcomes of older adults living in nursing homes: study protocol for a stepped wedge cluster randomized trial. Trials. 2021. PMID: 34727956. doi:10.1186/s13063-021-05729-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。